High Baseline Viremia: An Achilles Heel for Integrase Inhibitor-Based Antiretroviral Therapy? [PDF]
McCluskey SM, Marconi VC.
europepmc +1 more source
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. [PDF]
Leonard MA+19 more
europepmc +1 more source
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance [PDF]
M. Tschochner+9 more
openalex +1 more source
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. [PDF]
Álvarez H+32 more
europepmc +1 more source
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors [PDF]
Erik Serrao+3 more
openalex +1 more source
Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP. [PDF]
Enose-Akahata Y+10 more
europepmc +1 more source
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality [PDF]
Xue Zhi Zhao+4 more
openalex +1 more source
Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy. [PDF]
Lu H+20 more
europepmc +1 more source
Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts. [PDF]
Monroe AK+10 more
europepmc +1 more source
HIV-1 Integrase and Virus and Cell DNAs: Complex Formation and Perturbation by Inhibitors of Integration [PDF]
Zeina Hobaika+5 more
openalex +1 more source